Form 8-K - Current report:
SEC Accession No. 0001641172-25-012192
Filing Date
2025-05-23
Accepted
2025-05-23 09:22:59
Documents
15
Period of Report
2025-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38545
2 EX-3.1 ex3-1.htm EX-3.1 889
3 GRAPHIC ex3-1_001.jpg GRAPHIC 404787
  Complete submission text file 0001641172-25-012192.txt   766609

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE maia-20250522.xsd EX-101.SCH 3024
5 XBRL LABEL FILE maia-20250522_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE maia-20250522_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3901
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25979573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)